Showing results (51-60 of 132) with videos related to

Sort By:
Pageof 14
Progress in Clinical and Biological Research|January 1, 1991
Successful treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection explained by inhibitory effect on the immune response?B G Hansson, K Riesbeck, E Nordenfelt, et al.
Infection|November 1, 1990
Acute hepatitis B and hepatitis D co-infection in the Stockholm region in the 1970s and 1980s--a comparisonG Lindh, L Mattsson, M von Sydow, et al.
Journal of Medical Virology|May 1, 1995
Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon aloneR Schvarcz, Z B Yun, A Sönnerborg, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1994
Seroconversion after additional vaccine doses to non-responders to three doses of intradermally or intramuscularly administered recombinant hepatitis B vaccineJ Struve, B Aronsson, B Frenning, et al.
Journal of Hepatology|January 1, 1990
Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alfa-2b: Swedish experienceO Weiland, R Schvarcz, R Wejstål, et al.
Infection|September 1, 1994
Treatment of chronic replicative hepatitis B virus infection with short-term continuous infusion of foscarnetR Schvarcz, B G Hansson, J O Lernestedt, et al.
Journal of Medical Virology|August 13, 1998
Variation in the hepatitis C virus NS5a region in relation to hypervariable region 1 heterogeneity during interferon treatmentJ Odeberg, Z Yun, A Sönnerborg, et al.
The Journal of Infection|November 1, 1995
Risk factors for hepatitis A, B and C virus infection among Swedish expatriatesJ Struve, O Norrbohm, J Stenbeck, et al.
Infection|January 1, 1995
Response to a booster dose 18 months after a low anti-HBs response (10-99 IU/l) to three doses of intradermally or intramuscularly administered recombinant hepatitis B vaccineJ Struve, B Aronsson, B Frenning, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1988
Non-A, non-B hepatitis after open-heart surgery in Stockholm: declining incidence after introduction of restrictions for blood donations due to the human immunodeficiency virusL Mattsson, B Aberg, O Weiland, et al.
Pageof 14